靶向急性髓系白血病中的异柠檬酸脱氢酶1和2突变：新出现的选择与待解决的问题 - Suppr

Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia: Emerging Options and Pending Questions.

作者信息

Wouters Bas J

机构信息

Department of Hematology, Erasmus MC Cancer Center, Rotterdam, The Netherlands.

出版信息

Hemasphere. 2021 Jun 1;5(6):e583. doi: 10.1097/HS9.0000000000000583. eCollection 2021 Jun.

DOI:10.1097/HS9.0000000000000583

PMID:34095766

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8171378/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5da1/8171378/de22dd472850/hs9-5-e583-g001.jpg

相似文献

Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia: Emerging Options and Pending Questions.

Hemasphere. 2021 Jun 1;5(6):e583. doi: 10.1097/HS9.0000000000000583. eCollection 2021 Jun.

IDH1/IDH2 Inhibition in Acute Myeloid Leukemia.

Front Oncol. 2021 Mar 29;11:639387. doi: 10.3389/fonc.2021.639387. eCollection 2021.

Emerging drug profile: Krebs cycle and cancer: IDH mutations and therapeutic implications.

Leuk Lymphoma. 2019 Nov;60(11):2635-2645. doi: 10.1080/10428194.2019.1602260. Epub 2019 Apr 8.

Mutation Analysis of Isocitrate Dehydrogenase (IDH1/2) and DNA Methyltransferase 3A (DNMT3A) in Thai Patients with Newly Diagnosed Acute Myeloid Leukemia.

Asian Pac J Cancer Prev. 2017 Feb 1;18(2):413-420. doi: 10.22034/APJCP.2017.18.2.413.

Effects of azacitidine in 93 patients with mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study.

Leuk Lymphoma. 2021 Feb;62(2):438-445. doi: 10.1080/10428194.2020.1832661. Epub 2020 Oct 12.

Immunohistochemical loss of 5-hydroxymethylcytosine expression in acute myeloid leukaemia: relationship to somatic gene mutations affecting epigenetic pathways.

Histopathology. 2016 Dec;69(6):1055-1065. doi: 10.1111/his.13046. Epub 2016 Sep 23.

IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives.

J Blood Med. 2016 Sep 2;7:171-80. doi: 10.2147/JBM.S70716. eCollection 2016.

IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia.

Cancer Res. 2015 May 15;75(10):2005-16. doi: 10.1158/0008-5472.CAN-14-2200. Epub 2015 Mar 20.

Digital Droplet PCR is a Specific and Sensitive Tool for Detecting IDH2 Mutations in Acute Myeloid LeuKemia Patients.

Cancers (Basel). 2020 Jun 30;12(7):1738. doi: 10.3390/cancers12071738.

IDH1/2 Mutations Predict Shorter Survival in Chondrosarcoma.

J Cancer. 2018 Feb 28;9(6):998-1005. doi: 10.7150/jca.22915. eCollection 2018.

引用本文的文献

Functional cure with single agent olutasidenib in relapsed IDH1/NPM1 co-mutated AML.

NPJ Precis Oncol. 2025 Jul 1;9(1):211. doi: 10.1038/s41698-025-01013-5.

Invasive Fungal Disease Associated With Targeted Agents for Acute Myeloid Leukaemia: A Systematic Review.

EJHaem. 2025 Mar 10;6(2):e1105. doi: 10.1002/jha2.1105. eCollection 2025 Apr.

Comprehensive biomarker profiles in hematological malignancies: improving diagnosis, prognosis, and treatment.

Biomark Med. 2025 Mar;19(6):223-238. doi: 10.1080/17520363.2025.2471745. Epub 2025 Feb 27.

Inducing apoptosis in acute myeloid leukemia; mechanisms and limitations.

Heliyon. 2024 Dec 19;11(1):e41355. doi: 10.1016/j.heliyon.2024.e41355. eCollection 2025 Jan 15.

Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia.

Pharmaceutics. 2024 Mar 22;16(4):442. doi: 10.3390/pharmaceutics16040442.

Genetic mutations affecting mitochondrial function in cancer drug resistance.

Genes Genomics. 2023 Mar;45(3):261-270. doi: 10.1007/s13258-022-01359-1. Epub 2023 Jan 7.

Role of Biomarkers in the Management of Acute Myeloid Leukemia.

Int J Mol Sci. 2022 Nov 22;23(23):14543. doi: 10.3390/ijms232314543.

CpG Island Methylator Phenotype-A Hope for the Future or a Road to Nowhere?

Int J Mol Sci. 2022 Jan 13;23(2):830. doi: 10.3390/ijms23020830.

本文引用的文献

Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia.

J Clin Oncol. 2021 Jan 1;39(1):57-65. doi: 10.1200/JCO.20.01632. Epub 2020 Oct 29.

Effects of azacitidine in 93 patients with mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study.

Leuk Lymphoma. 2021 Feb;62(2):438-445. doi: 10.1080/10428194.2020.1832661. Epub 2020 Oct 12.

Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study.

Blood. 2021 Apr 1;137(13):1792-1803. doi: 10.1182/blood.2020007233.

IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction-a retrospective propensity score analysis.

Leukemia. 2021 May;35(5):1301-1316. doi: 10.1038/s41375-020-01043-x. Epub 2020 Sep 18.

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.

N Engl J Med. 2020 Aug 13;383(7):617-629. doi: 10.1056/NEJMoa2012971.

Isocitrate dehydrogenase variants in cancer - Cellular consequences and therapeutic opportunities.

Curr Opin Chem Biol. 2020 Aug;57:122-134. doi: 10.1016/j.cbpa.2020.06.012. Epub 2020 Aug 8.

Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results.

Leukemia. 2020 Nov;34(11):2903-2913. doi: 10.1038/s41375-020-0996-5. Epub 2020 Jul 30.

Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis.

Clin Cancer Res. 2020 Aug 15;26(16):4280-4288. doi: 10.1158/1078-0432.CCR-20-0834. Epub 2020 May 11.

Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML.

Blood Adv. 2020 May 12;4(9):1894-1905. doi: 10.1182/bloodadvances.2020001503.

Neoantigens in Hematological Malignancies-Ultimate Targets for Immunotherapy?

Front Immunol. 2019 Dec 20;10:3004. doi: 10.3389/fimmu.2019.03004. eCollection 2019.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia: Emerging Options and Pending Questions.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献